News Related to Nirmatrelvir/Ritonavir

Related coverage linked through entity extraction aliases.

Pharmaceutical Stocks to Watch Include Eli Lilly, AbbVie, Vertex, Gilead and Pfizer

Apr 23, 2026

Eli Lilly, AbbVie, Vertex, Gilead Sciences and Pfizer were identified as pharmaceutical stocks to watch, with Abbott Laboratories and McKesson appearing on a separate seven-stock list.

Pfizer Plans Obesity Drug Launch Drawing on Viagra Rollout Experience

Mar 08, 2026

Pfizer is applying lessons from its Viagra launch to introduce its first obesity treatment, a monthly injection acquired from Metsera. The company aims to leverage past experience with sensitive health topics as it enters the competitive obesity market.